Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML

Clinical trial NCT02474290 · COMPLETED

Trial details

NCT number: NCT02474290
Sponsor: Nanfang Hospital, Southern Medical University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Hematopoietic Stem Cell Transplantation

Start date: 2015-06-20
Primary completion: 2018-07-21
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.